A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...
In mCRPC patients with BRCA1/2 or ATM alterations, first-line treatment with abiraterone plus prednisone and olaparib improves OS.
BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, ...
National Cancer Institute/Unsplash An estimated 170,000 Australians were diagnosed with cancer in 2025.Authors Sarah Diepstraten Senior Research ...
While the genes involved can differ, this example illustrates how most cancers arise. Accumulated DNA mutations, acquired either over time (ageing naturally leads to some DNA mistakes) or from ...
Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results